CD274 and chronic myelogenous leukemia, BCR-ABL1 positive: These data suggest that high expression of PD-L1 on basophils and monocytes (also reported as monocytic-MDSCs), both of which are known to be increased in absolute numbers in CML patients13,44, may also contribute to compromised anti-tumor immunity.